Target Validation Information
Target ID T76937
Target Name Voltage-gated sodium channel subunit alpha Nav1.3
Target Type
Successful
Drug Potency against Target SIPATRIGINE Drug Info IC50 = 17850 nM [526398]
4-Biphenyl-4-yl-2-(1-propyl-butyl)-1H-imidazole Drug Info IC50 = 100 nM [527102]
LIDOFLAZINE Drug Info Ki = 77 nM [533974]
L-741742 Drug Info Ki = 1900 nM [525540]
CCNCSSKWCRDHSRCC Drug Info IC50 = 8000 nM [529000]
U-92032 Drug Info IC50 = 360 nM [525864]
4-Biphenyl-4-yl-2-methyl-1H-imidazole Drug Info IC50 = 1460 nM [527102]
5-Hexyl-5-phenyl-imidazolidine-2,4-dione Drug Info IC50 = 13000 nM [525483]
5-Nonyl-5-phenyl-imidazolidine-2,4-dione Drug Info IC50 = 5000 nM [525483]
2-Hydroxy-2-phenyl-nonanoic acid amide Drug Info IC50 = 9000 nM [525483]
4-Biphenyl-4-yl-2-(1-pentyl-hexyl)-1H-imidazole Drug Info IC50 = 8 nM [527102]
2-(1-Pentyl-hexyl)-4-phenyl-1H-imidazole Drug Info IC50 = 86 nM [527102]
4-Biphenyl-4-yl-2-cyclohexylmethyl-1H-imidazole Drug Info IC50 = 70 nM [527102]
PD-85639 Drug Info Ki = 260 nM [533974]
5-Heptyl-5-phenyl-imidazolidine-2,4-dione Drug Info IC50 = 5000 nM [525483]
4-Biphenyl-4-yl-2-hexyl-1H-imidazole Drug Info IC50 = 16 nM [527102]
2-Hexyl-4-(4-isobutyl-phenyl)-1H-imidazole Drug Info IC50 = 28 nM [527102]
References
Ref 526398J Med Chem. 2002 Aug 15;45(17):3755-64.Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 533974J Med Chem. 1994 Jan 21;37(2):268-74.Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers.
Ref 525540J Med Chem. 1999 Jul 15;42(14):2706-15.1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1, 3-dihydroimidazol-2-one: a selective high-affinity antagonist for the human dopamine D(4) receptor with excellent selectivity over ion channels.
Ref 529000J Biol Chem. 2007 Oct 19;282(42):30699-706. Epub 2007 Aug 27.Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels.
Ref 525864J Med Chem. 2000 Sep 7;43(18):3372-6.Discovery of (2S)-1-(4-amino-2,3,5- trimethylphenoxy)-3-[4-[4-(4- fluorobenzyl)phenyl]-1-piperazinyl]-2-propanol dimethanesulfonate (SUN N8075): a dual Na(+) and Ca(2+) channel blocker with antioxidant activity.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 525483J Med Chem. 1999 May 6;42(9):1537-45.Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
Ref 525483J Med Chem. 1999 May 6;42(9):1537-45.Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
Ref 525483J Med Chem. 1999 May 6;42(9):1537-45.Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 533974J Med Chem. 1994 Jan 21;37(2):268-74.Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers.
Ref 525483J Med Chem. 1999 May 6;42(9):1537-45.Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.